Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
5.41
-0.17 (-3.05%)
At close: Oct 29, 2025, 4:00 PM EDT
5.00
-0.41 (-7.58%)
Pre-market: Oct 30, 2025, 8:34 AM EDT

Vanda Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
212.07198.77192.64254.38268.68248.17
Upgrade
Revenue Growth (YoY)
11.12%3.18%-24.27%-5.32%8.27%9.23%
Upgrade
Cost of Revenue
11.811.3114.824.2825.6323.36
Upgrade
Gross Profit
200.27187.46177.84230.1243.05224.8
Upgrade
Selling, General & Admin
214.26146.41112.88136.49124.05140.51
Upgrade
Research & Development
100.1174.4376.8285.7775.3655.58
Upgrade
Amortization of Goodwill & Intangibles
7.017.272.091.521.481.48
Upgrade
Operating Expenses
321.37228.12191.8223.77200.89197.57
Upgrade
Operating Income
-121.09-40.66-13.956.3342.1727.24
Upgrade
Interest & Investment Income
-----4.42
Upgrade
Other Non Operating Income (Expenses)
6.9610.7511.492.011.85-
Upgrade
EBT Excluding Unusual Items
-114.14-29.92-2.468.3444.0131.66
Upgrade
Gain (Loss) on Sale of Investments
6.996.998.82.96-1.65-
Upgrade
Pretax Income
-107.14-22.926.3411.342.3631.66
Upgrade
Income Tax Expense
-22.94-4.023.835.039.218.32
Upgrade
Net Income
-84.2-18.92.516.2833.1523.34
Upgrade
Net Income to Common
-84.2-18.92.516.2833.1523.34
Upgrade
Net Income Growth
---60.02%-81.07%42.06%-79.80%
Upgrade
Shares Outstanding (Basic)
595857565654
Upgrade
Shares Outstanding (Diluted)
595858575755
Upgrade
Shares Change (YoY)
1.34%1.03%1.01%0.11%3.14%0.63%
Upgrade
EPS (Basic)
-1.43-0.330.040.110.600.43
Upgrade
EPS (Diluted)
-1.44-0.330.040.110.580.42
Upgrade
EPS Growth
---63.64%-81.03%38.09%-80.09%
Upgrade
Free Cash Flow
--20.48-88.2531.3163.6649.98
Upgrade
Free Cash Flow Per Share
--0.35-1.530.551.120.91
Upgrade
Gross Margin
94.44%94.31%92.32%90.45%90.46%90.59%
Upgrade
Operating Margin
-57.10%-20.46%-7.24%2.49%15.69%10.98%
Upgrade
Profit Margin
-39.70%-9.51%1.30%2.47%12.34%9.40%
Upgrade
Free Cash Flow Margin
--10.30%-45.81%12.31%23.69%20.14%
Upgrade
EBITDA
-113.07-32.53-10.949.0645.0130.1
Upgrade
EBITDA Margin
-53.31%-16.36%-5.68%3.56%16.75%12.13%
Upgrade
D&A For EBITDA
8.038.133.012.732.842.86
Upgrade
EBIT
-121.09-40.66-13.956.3342.1727.24
Upgrade
EBIT Margin
-57.10%-20.46%-7.24%2.49%15.69%10.98%
Upgrade
Effective Tax Rate
--60.42%44.47%21.75%26.28%
Upgrade
Revenue as Reported
212.07198.77192.64254.38268.68248.17
Upgrade
Updated Oct 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q